CTVA

Corteva, Inc. NYSE

Basic Materials ·Agricultural Inputs ·US · corteva.com

$80.85

After hrs $81.69 -0.04%

Mkt Cap $54.4B

52w Low $60.53 81.0% of range 52w High $85.63

50d MA $80.13 200d MA $71.64

P/E (TTM) 50.2x

EV/EBITDA 14.1x

P/B 2.2x

Debt/Equity 0.1x

ROE 4.5%

P/FCF 16.0x

RSI (14) —

ATR (14) —

Beta 0.68

50d MA $80.13

200d MA $71.64

Avg Volume 4.1M

About

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segmen…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 3, 2026	AMC	0.22	0.22	-1.3%	75.04	-2.6%	+0.1%	-3.4%	-3.3%	-1.9%	-1.1%	+2.1%	—
Nov 4, 2025	AMC	-0.51	-0.23	+54.6%	62.50	+3.5%	+1.9%	+1.0%	+2.6%	+4.9%	+5.2%	+6.1%	—
Aug 6, 2025	AMC	1.89	2.20	+16.4%	71.17	-0.9%	-0.2%	-0.4%	+1.8%	-0.2%	+1.6%	+1.6%	—
May 7, 2025	AMC	0.87	1.13	+29.3%	62.48	+3.4%	+7.0%	+8.5%	+8.8%	+8.7%	+8.2%	+14.7%	—
Feb 5, 2025	AMC	0.31	0.32	+2.5%	63.82	-0.4%	-2.3%	-2.3%	-2.5%	-1.3%	-2.8%	-5.1%	—
Nov 6, 2024	AMC	-0.30	-0.49	-61.7%	61.74	-6.1%	-5.0%	-5.5%	-5.2%	-7.5%	-6.6%	-3.6%	—
Jul 31, 2024	AMC	1.73	1.83	+5.8%	56.10	-3.8%	-5.5%	-8.1%	-8.5%	-8.8%	-9.5%	+2.1%	—
May 1, 2024	AMC	0.82	0.89	+8.1%	53.91	+5.7%	+5.7%	+6.0%	+4.5%	+6.7%	+5.4%	+3.8%	—
Jan 31, 2024	AMC	0.06	0.15	+155.5%	45.48	+24.2%	+18.9%	+16.6%	+13.9%	+14.5%	+18.9%	+18.0%	—
Nov 8, 2023	AMC	-0.26	-0.23	+11.5%	48.62	+2.2%	-8.5%	-10.4%	-6.8%	-4.8%	-3.9%	-7.1%	—
Aug 3, 2023	AMC	1.58	1.60	+1.3%	55.69	-1.1%	+0.6%	-2.0%	-2.7%	-4.2%	-6.2%	-8.5%	—
May 3, 2023	AMC	0.93	1.16	+24.7%	60.00	+0.6%	-5.2%	-2.9%	-4.0%	-4.8%	-4.0%	-6.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	RBC Capital	Maintains	Outperform → Outperform	—	$79.63	$79.40	-0.3%	+0.2%	-0.3%	-0.9%	-0.3%	+1.7%
Apr 22	Oppenheimer	Maintains	Outperform → Outperform	—	$80.35	$80.66	+0.4%	-1.2%	-0.9%	-0.7%	-1.2%	-1.8%
Apr 21	Wells Fargo	Maintains	Overweight → Overweight	—	$80.29	$80.57	+0.3%	+0.1%	-1.2%	-0.8%	-0.6%	-1.1%
Apr 9	UBS	Maintains	Neutral → Neutral	—	$83.96	$84.04	+0.1%	-0.5%	-0.2%	-0.5%	-1.2%	-3.1%
Mar 31	Argus	Maintains	Buy → Buy	—	$82.95	$83.00	+0.1%	+0.9%	+1.0%	+3.0%	+1.6%	+2.9%
Feb 17	Mizuho	Maintains	Outperform → Outperform	—	$75.03	$75.19	+0.2%	+0.7%	+2.1%	+2.7%	+1.7%	+1.9%
Feb 5	RBC Capital	Maintains	Outperform → Outperform	—	$75.12	$74.41	-0.9%	-3.5%	-3.4%	-2.0%	-1.2%	+0.3%
Feb 5	JP Morgan	Downgrade	Overweight → Neutral	—	$75.12	$74.41	-0.9%	-3.5%	-3.4%	-2.0%	-1.2%	+0.3%
Feb 5	Wells Fargo	Maintains	Overweight → Overweight	—	$75.12	$74.41	-0.9%	-3.5%	-3.4%	-2.0%	-1.2%	+0.3%
Feb 5	Citigroup	Maintains	Neutral → Neutral	—	$75.12	$74.41	-0.9%	-3.5%	-3.4%	-2.0%	-1.2%	+0.3%
Jan 27	Oppenheimer	Maintains	Outperform → Outperform	—	$72.63	$72.61	-0.0%	+0.5%	+0.6%	+1.7%	+0.2%	+0.8%
Jan 21	JP Morgan	Maintains	Overweight → Overweight	—	$68.90	$70.34	+2.1%	+3.7%	+3.9%	+4.1%	+5.4%	+6.0%
Jan 21	Citigroup	Maintains	Neutral → Neutral	—	$68.90	$70.34	+2.1%	+3.7%	+3.9%	+4.1%	+5.4%	+6.0%
Jan 16	Mizuho	Maintains	Outperform → Outperform	—	$70.50	$69.49	-1.4%	-1.2%	-2.3%	+1.4%	+1.5%	+1.7%
Dec 18	Citigroup	Maintains	Neutral → Neutral	—	$66.43	$66.83	+0.6%	+0.8%	-0.2%	+1.0%	+1.1%	+1.4%
Nov 11	Wells Fargo	Maintains	Overweight → Overweight	—	$65.56	$65.54	-0.0%	+0.2%	+1.4%	+1.0%	+0.7%	-2.6%
Oct 30	UBS	Maintains	Buy → Buy	—	$63.20	$61.28	-3.0%	-2.4%	-2.8%	-1.8%	-1.1%	+0.7%
Oct 16	Wells Fargo	Maintains	Overweight → Overweight	—	$61.91	$62.00	+0.1%	-1.5%	-0.8%	+0.1%	+0.1%	+2.0%
Oct 13	Argus	Maintains	Buy → Buy	—	$61.83	$62.27	+0.7%	+1.4%	+1.4%	+0.1%	-1.3%	-0.7%
Oct 8	Mizuho	Maintains	Outperform → Outperform	—	$65.61	$65.18	-0.7%	-3.8%	-4.4%	-5.8%	-4.5%	-4.5%
Oct 6	UBS	Maintains	Buy → Buy	—	$63.37	$63.52	+0.2%	+1.5%	+3.5%	-0.4%	-1.0%	-2.4%
Oct 3	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$63.49	$62.50	-1.6%	-0.2%	+1.3%	+3.3%	-0.6%	-1.2%
Oct 2	Citigroup	Downgrade	Buy → Neutral	—	$61.47	$61.33	-0.2%	+3.3%	+3.1%	+4.6%	+6.7%	+2.7%
Oct 2	JP Morgan	Upgrade	Neutral → Overweight	—	$61.47	$61.33	-0.2%	+3.3%	+3.1%	+4.6%	+6.7%	+2.7%
Aug 13	Barclays	Upgrade	Equal Weight → Overweight	—	$71.03	$72.04	+1.4%	+1.8%	+1.2%	+1.0%	+1.8%	+1.9%
Aug 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$71.05	$71.30	+0.4%	-0.2%	+2.0%	-0.0%	+1.8%	+1.2%
Aug 8	Wells Fargo	Maintains	Overweight → Overweight	—	$71.05	$71.30	+0.4%	-0.2%	+2.0%	-0.0%	+1.8%	+1.2%
Aug 7	UBS	Maintains	Buy → Buy	—	$71.17	$70.51	-0.9%	-0.2%	-0.4%	+1.8%	-0.2%	+1.6%
Jul 17	Argus	Maintains	Buy → Buy	—	$72.98	$73.02	+0.1%	+0.3%	+0.1%	+0.0%	+1.1%	+1.3%
Jul 15	Oppenheimer	Maintains	Outperform → Outperform	—	$73.11	$73.37	+0.4%	-1.4%	-0.2%	+0.1%	-0.1%	-0.2%
Jul 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$73.57	$73.78	+0.3%	-0.6%	-2.0%	-0.8%	-0.5%	-0.7%
Jul 10	RBC Capital	Maintains	Outperform → Outperform	—	$76.20	$76.07	-0.2%	-1.8%	-3.5%	-4.1%	-5.4%	-4.2%
Jul 9	UBS	Maintains	Buy → Buy	—	$76.45	$76.57	+0.2%	-0.3%	-2.1%	-3.8%	-4.4%	-5.7%
Jul 8	BMO Capital	Maintains	Outperform → Outperform	—	$76.58	$76.90	+0.4%	-0.2%	-0.5%	-2.3%	-3.9%	-4.5%
Jul 8	Citigroup	Maintains	Outperform → Outperform	—	$76.58	$76.90	+0.4%	-0.2%	-0.5%	-2.3%	-3.9%	-4.5%
Jul 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$77.12	$77.08	-0.1%	-0.7%	-0.9%	-1.2%	-3.0%	-4.6%
Jun 26	Citigroup	Maintains	Buy → Buy	—	$73.24	$73.96	+1.0%	+1.4%	+1.6%	+1.8%	+2.6%	+5.1%
Jun 23	Wells Fargo	Maintains	Overweight → Overweight	—	$73.72	$73.79	+0.1%	+1.0%	-0.6%	-0.7%	+0.8%	+0.9%
Jun 6	Jefferies	Maintains	Buy → Buy	—	$71.20	$71.42	+0.3%	+0.6%	+1.1%	+0.5%	+1.2%	+1.9%
May 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$67.90	$67.43	-0.7%	-0.5%	+0.6%	+1.0%	+1.3%	+1.9%
May 12	Wells Fargo	Maintains	Overweight → Overweight	—	$67.79	$69.13	+2.0%	+0.3%	+0.2%	-0.3%	+0.7%	+1.2%
May 9	Oppenheimer	Maintains	Outperform → Outperform	—	$66.86	$66.71	-0.2%	+1.4%	+1.6%	+1.6%	+1.1%	+2.1%
May 9	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$66.86	$66.71	-0.2%	+1.4%	+1.6%	+1.6%	+1.1%	+2.1%
May 9	Citigroup	Maintains	Buy → Buy	—	$66.86	$66.71	-0.2%	+1.4%	+1.6%	+1.6%	+1.1%	+2.1%
May 9	Morgan Stanley	Maintains	Overweight → Overweight	—	$66.86	$66.71	-0.2%	+1.4%	+1.6%	+1.6%	+1.1%	+2.1%
May 8	UBS	Maintains	Buy → Buy	—	$62.48	$64.63	+3.4%	+7.0%	+8.5%	+8.8%	+8.7%	+8.2%
Apr 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$59.28	$59.88	+1.0%	+1.7%	+0.7%	-0.1%	+0.8%	-0.3%
Mar 31	Argus	Upgrade	Hold → Buy	—	$61.06	$61.30	+0.4%	+3.1%	+4.1%	+4.8%	+0.4%	-8.6%
Feb 11	BofA Securities	Maintains	Buy → Buy	—	$62.21	$62.08	-0.2%	+1.2%	-0.2%	+1.0%	+2.8%	+3.6%
Feb 7	Oppenheimer	Maintains	Outperform → Outperform	—	$62.36	$62.50	+0.2%	-0.0%	-0.2%	+1.0%	-0.5%	+0.8%

Recent Filings

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Corteva announced key executive leadership appointments for a planned spinoff structure, signaling management readiness for separation and potential operational independence of two entities.

Apr 14

8-K

Corteva, Inc. -- 8-K Filing

Corteva reported fourth-quarter 2025 results with net sales and continued operating losses, potentially signaling ongoing profitability challenges for the agricultural biotechnology company.

Feb 3

Data updated apr 25, 2026 3:52am · Source: massive.com